Beginning today, those getting a monkeypox vaccine in New York City will receive an intradermal injection of the Jynneos vaccine as part of a dose-sparing strategy. The city immediately opened 12,000 vaccine slots upon announcing the decision yesterday.

In other US news, North Carolina reported a pediatric monkeypox case.

Vaccine scarcity in US, globally

"As we continue to see a scarcity of federal supply of monkeypox vaccines, we must adapt to provide a range of options to those who are vaccine-eligible, and to do so in an equitable way," said New York City Health Commissioner Ashwin Vasan, MD, PhD, in a press statement.

"The Health Department is working to balance these considerations and the concerns we've heard from community advocates under supply constraints."

The city said information about second doses will be released next week.

Intradermal dosing, which stretches one subcutaneous dose to five by injecting the vaccine under the first layer of the skin, is being used to boost the supply of Bavarian Nordic's vaccine. The company said today it was looking at using technically expired doses of vaccine as another means to increase supply.

Bavarian Nordic CEO Paul Chaplin, PhD, told Reuters the global demand for the vaccine is "exceeding our ability to deliver."

Read more...